Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Rowe

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
BJU International|October 7, 2017
Cost analysis of open radical cystectomy versus robot-assisted radical cystectomySukhchain S Bansal, Tara Dogra, Peter W Smith, et al.
BJUI Compass|October 17, 2024
National audit of patient reported experience of radical cystectomy for bladder cancer pathwaysPreksha Kuppanda, Louisa Hermans, Alan Uren, et al.
BMJ Open|June 29, 2022
Attitudes and adherence to changes in nutrition and physical activity following surgery for prostate cancer: a qualitative studyLuke A Robles, Ellie Shingler, Lucy McGeagh, et al.
Trials|March 8, 2017
The feasibility of the Prostate cancer: Evidence of Exercise and Nutrition Trial (PrEvENT) dietary and physical activity modifications: a qualitative studyEllie Shingler, Lucy Hackshaw-McGeagh, Luke Robles, et al.
Oncotarget|July 14, 2020
IGF-1 and hyperglycaemia-induced FOXA1 and IGFBP-2 affect epithelial to mesenchymal transition in prostate epithelial cellsRehanna Mansor, Jeff Holly, Rachel Barker, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|April 22, 2023
Associations of CTCF and FOXA1 with androgen and IGF pathways in men with localized prostate cancerRachel Barker, Kalina Biernacka, Georgina Kingshott, et al.
Clinical Genitourinary Cancer|March 17, 2021
A Single-arm Phase II Trial of Neoadjuvant Cabazitaxel and Cisplatin Chemotherapy for Muscle-Invasive Transitional Cell Carcinoma of the Urinary BladderAmarnath Challapalli, Susan Masson, Paul White, et al.
BMJ Open|August 11, 2018
Robot-assisted radical cystectomy with intracorporeal urinary diversion versus open radical cystectomy (iROC): protocol for a randomised controlled trial with internal feasibility studyJames W F Catto, Pramit Khetrapal, Gareth Ambler, et al.
Cancers|January 28, 2026
Correction: Kingshott et al. Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate Cancer. <i>Cancers</i> 2021, <i>13</i>, 825Georgina Kingshott, Kalina Biernacka, Alex Sewell, et al.
Cancers|March 6, 2021
Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate CancerGeorgina Kingshott, Kalina Biernacka, Alex Sewell, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
BJU International|October 7, 2017
Cost analysis of open radical cystectomy versus robot-assisted radical cystectomySukhchain S Bansal, Tara Dogra, Peter W Smith, et al.
BJUI Compass|October 17, 2024
National audit of patient reported experience of radical cystectomy for bladder cancer pathwaysPreksha Kuppanda, Louisa Hermans, Alan Uren, et al.
BMJ Open|June 29, 2022
Attitudes and adherence to changes in nutrition and physical activity following surgery for prostate cancer: a qualitative studyLuke A Robles, Ellie Shingler, Lucy McGeagh, et al.
Trials|March 8, 2017
The feasibility of the Prostate cancer: Evidence of Exercise and Nutrition Trial (PrEvENT) dietary and physical activity modifications: a qualitative studyEllie Shingler, Lucy Hackshaw-McGeagh, Luke Robles, et al.
Oncotarget|July 14, 2020
IGF-1 and hyperglycaemia-induced FOXA1 and IGFBP-2 affect epithelial to mesenchymal transition in prostate epithelial cellsRehanna Mansor, Jeff Holly, Rachel Barker, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|April 22, 2023
Associations of CTCF and FOXA1 with androgen and IGF pathways in men with localized prostate cancerRachel Barker, Kalina Biernacka, Georgina Kingshott, et al.
Clinical Genitourinary Cancer|March 17, 2021
A Single-arm Phase II Trial of Neoadjuvant Cabazitaxel and Cisplatin Chemotherapy for Muscle-Invasive Transitional Cell Carcinoma of the Urinary BladderAmarnath Challapalli, Susan Masson, Paul White, et al.
BMJ Open|August 11, 2018
Robot-assisted radical cystectomy with intracorporeal urinary diversion versus open radical cystectomy (iROC): protocol for a randomised controlled trial with internal feasibility studyJames W F Catto, Pramit Khetrapal, Gareth Ambler, et al.
Cancers|January 28, 2026
Correction: Kingshott et al. Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate Cancer. <i>Cancers</i> 2021, <i>13</i>, 825Georgina Kingshott, Kalina Biernacka, Alex Sewell, et al.
Cancers|March 6, 2021
Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate CancerGeorgina Kingshott, Kalina Biernacka, Alex Sewell, et al.
Pageof 4